Safety, pharmacokinetics, and pharmacodynamics of pegozafermin in patients with non-alcoholic steatohepatitis: a randomised, double-blind, placebo-controlled, phase 1b/2a multiple-ascending-dose study - Loomba, R; Lawitz, E J; Frias, J P (Lancet Gastroenterol Hepatol, 2023)